UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 535

Sortiert nach

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (22), p.2965-2971

2011

Volltextzugriff (PDF)

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3337-3344

2012

Volltextzugriff (PDF)

Extranodal NK / T‐cell lymphoma, nasal type: New staging system and treatment strategies

Cancer science, 2009-12, Vol.100 (12), p.2242-2248

2009

Volltextzugriff (PDF)

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2493-2501

2005

Volltextzugriff (PDF)

Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer

Japanese journal of clinical oncology, 2020-02, Vol.50 (2), p.185-192

2020

Volltextzugriff (PDF)

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5233-5239

2007

Volltextzugriff (PDF)

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Clinical cancer research, 2006-04, Vol.12 (8), p.2538-2544

2006

Volltextzugriff (PDF)

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type

Blood, 2005-12, Vol.106 (12), p.3785-3790

2005

Volltextzugriff (PDF)

Anthelmintics as Potential Anti-Cancer Drugs?

Journal of Korean Medical Science, 2020, 35(6), , pp.1-2

Heo, Dae Seog

2020

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small cell lung cancer

International journal of cancer, 2005-01, Vol.113 (1), p.109-115

2005

Volltextzugriff (PDF)

First‐line therapy with doxycycline in ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors

Cancer science, 2010-05, Vol.101 (5), p.1199-1203

2010

Volltextzugriff (PDF)

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

BMC cancer, 2010-08, Vol.10 (1), p.448-448, Article 448

2010

Volltextzugriff (PDF)

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

Scientific reports, 2021-10, Vol.11 (1), p.19712-11, Article 19712

2021

Volltextzugriff (PDF)

Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers

Nature communications, 2017-10, Vol.8 (1), p.1050-13, Article 1050

2017

Volltextzugriff (PDF)

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

Leukemia, 2020-08, Vol.34 (8), p.2184-2197

2020

Volltextzugriff (PDF)

Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor

PloS one, 2018-01, Vol.13 (1), p.e0189766-e0189766

2018

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis

JAMA : the journal of the American Medical Association, 2014-04, Vol.311 (14), p.1430

2014

Volltextzugriff (PDF)

Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors

BMC cancer, 2019-01, Vol.19 (1), p.19-19, Article 19

2019

Volltextzugriff (PDF)

Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines

Oncogene, 2005-10, Vol.24 (44), p.6689-6698

2005

Volltextzugriff (PDF)

Measuring the Structure and Process of End-of-Life Care in Korea: Validation of the Korean Version of the Care Evaluation Scale (CES)

Journal of pain and symptom management, 2012-10, Vol.44 (4), p.615-625.e2

2012

Volltextzugriff (PDF)

Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non–Small-Cell Lung Cancer

Clinical lung cancer, 2016-07, Vol.17 (4), p.263-270.e2

2016

Volltextzugriff (PDF)

Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer

Japanese journal of clinical oncology, 2012-10, Vol.42 (10), p.948-954

2012

Volltextzugriff (PDF)

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

Scientific reports, 2021-01, Vol.11 (1), p.2514-2514

2021

Volltextzugriff (PDF)

Clinical significance of tumor‐infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa‐associated lymphoid tissue lymphoma

Cancer science, 2011-11, Vol.102 (11), p.1972-1976

2011

Volltextzugriff (PDF)

1 – 25 von 535

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(499)

Publikationsform

Artikel
(534)
Berichte
(1)

Sprache

Englisch
(498)
Japanisch
(62)
Koreanisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(356)
Life Sciences & Biomedicine
(344)
Humans
(320)
Oncology
(267)
Female
(255)
Male
(246)
Middle Aged
(234)
Adult
(211)
Aged
(206)
Aged, 80 And Over
(98)
Biological And Medical Sciences
(97)
Medical Sciences
(95)
Prognosis
(95)
Retrospective Studies
(90)
Tumors
(83)
Treatment Outcome
(80)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(72)
Original
(72)
Chemotherapy
(71)
Lung Neoplasms - Drug Therapy
(65)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Extranodal NK / T‐cell lymphoma, nasal type: New staging system and treatment strategies

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type

Anthelmintics as Potential Anti-Cancer Drugs?

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small cell lung cancer

First‐line therapy with doxycycline in ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor

Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis

Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors

Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines

Measuring the Structure and Process of End-of-Life Care in Korea: Validation of the Korean Version of the Care Evaluation Scale (CES)

Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non–Small-Cell Lung Cancer

Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

Clinical significance of tumor‐infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa‐associated lymphoid tissue lymphoma

Suchergebnisse filtern